NinePoint Medical
8
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
Role: collaborator
Barrett's Dysplasia Detection Pilot Trial Using the NvisionVLE® Imaging System
Role: lead
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
Role: collaborator
NvisionVLE™ Registry System Registry
Role: lead
A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients With Barrett's Dysplasia or Intramucosal Adenocarcinoma
Role: lead
High Resolution Optical Imaging of Barrett's Esophagus Using Nvision Volumetric Laser Endomicroscopy (VLE)
Role: lead
High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging System
Role: lead
High Resolution Optical Imaging of the Esophagus Using the Nvision Volumetric Laser Endomicroscopy (VLE™) Imaging System
Role: lead
All 8 trials loaded